Annual Drug Patent Expirations for KORLYM
Korlym is a drug marketed by Corcept Therap and is included in one NDA. There are fourteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for KORLYM.
This drug has thirty-one patent family members in twelve countries.
The generic ingredient in KORLYM is mifepristone. Additional details are available on the mifepristone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
